How did Egypt’s pharma production fall from such great heights? In the 1960s and 1970s, pharma production in Egypt was on the rise in both quality and quantity as pioneers in the industry actively sought to develop the country’s know-how, which stands in stark contrast with contemporary practices, Nahed Youssef writes in a column penned for Al Shorouk. The decline was put in motion by Sadat’s economic policies, and was carried through by successive governments over the course of 50 years. Youssef says that Egypt has enough resources — in terms of a labor force, factories, and available capital — and simply needs the implementation of the correct policies to reverse the downward trend. Correct policies starting with a return to state socialism, Nasser style, right?
More from Enterprise
Banque du Caire’s blockbuster IPO holds firm against EGX selloff
The IFC and the EBRD are in for USD 100…
Can AI promise Egypt’s lenders more borrowers and fewer bad loans?
Banks are cautious about letting AI judge a borrower. Local…
Egypt’s funds crossed EGP 500 bn in 3Q on retail money and a stalling core
Money market funds stalled while retail piled into equity, index,…
DPI closes Egypt-born fintech fund Nclude at USD 112 mn
The final close adds roughly USD 7 mn to a…